证券记录 · 已归档季度
TARS
Tarsus Pharmaceuticals, Inc. · Healthcare · Biotechnology
11被追踪持有人
+2Δ持有人
4.92M持有股份
$252.88M报告持仓市值
+2新建仓位
−0清仓
动量输入（同类管理人）：
持有人广度 +22.2% ·
股份流向 +30.0% ·
净新建仓位 +18.2%
— 公式
广泛积累 — 持股数量上升且持有人增多
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q1 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 102 | +3 | 26.51M | $1.67B | +7 | −3 |
| Q1 2026 | 101 | +5 | 27.05M | $1.90B | +10 | −6 |
| Q4 2025 | 97 | 0 | 27.39M | $2.24B | +2 | −1 |
| Q3 2025 | 16 | 0 | 11.66M | $693.15M | +1 | −2 |
| Q2 2025 | 14 | 0 | 10.63M | $430.62M | — | — |
| Q1 2025 | 11 | +2 | 4.92M | $252.88M | +2 | — |
| Q4 2024 | 9 | 0 | 3.55M | $196.55M | — | — |
| Q3 2024 | 8 | 0 | 2.33M | $76.49M | — | — |
| Q2 2024 | 8 | — | 2.46M | $66.86M | — | — |
持有人 · Q1 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Citadel Advisors ✦ | 992.64K | +1151.1% | $50.99M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 2 | Citadel Advisors ✦ | 992.64K | +1151.1% | $50.99M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 3 | State Street Global Advisors ✦ (被动) | 910.72K | -0.7% | $46.78M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | Geode Capital Management ✦ (被动) | 865.43K | +3.2% | $44.47M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Geode Capital Management ✦ (被动) | 865.43K | +3.2% | $44.47M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | Adage Capital Partners ✦ | 510.00K | 新增 | $26.20M | 0.0% | New | 1 | SEC ↗ |
| 7 | T. Rowe Price ✦ | 433.17K | -6.0% | $22.25M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 8 | T. Rowe Price ✦ | 433.17K | -6.0% | $22.25M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 9 | D. E. Shaw & Co. ✦ | 410.68K | +12.3% | $21.10M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 10 | D. E. Shaw & Co. ✦ | 410.68K | +12.3% | $21.10M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 11 | Norges Bank ✦ (被动) | 391.06K | 新增 | $20.09M | 0.0% | New | 1 | SEC ↗ |
| 12 | Millennium Management ✦ | 247.19K | -61.6% | $12.70M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 13 | Wellington Management ✦ | 116.11K | -15.1% | $5.96M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 14 | Wellington Management ✦ | 116.11K | -15.1% | $5.96M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 15 | Wellington Management ✦ | 116.11K | -15.1% | $5.96M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 16 | Wellington Management ✦ | 116.11K | -15.1% | $5.96M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 17 | Two Sigma Investments ✦ | 29.28K | -67.9% | $1.50M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 16.22K | 0.0% | $833,428 | 0.0% | Held | 4 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 16.22K | 0.0% | $833,428 | 0.0% | Held | 4 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 16.22K | 0.0% | $833,428 | 0.0% | Held | 4 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 16.22K | 0.0% | $833,428 | 0.0% | Held | 4 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Adage Capital Partners | $26.20M | 0.0% |
| Norges Bank | $20.09M | 0.0% |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 252 持有人, 45.11M 股份, $3.08B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q1 2025 ·
方法论 ·
通过API获取此数据